期刊文献+

mEGF乙醇脂质体的制备和特性研究 被引量:1

Preparation of mEGF ethosome and its properties
下载PDF
导出
摘要 目的制备mEGF乙醇脂质体,并研究mEGF乙醇脂质体囊泡的包封率和物理性质。方法采用高效液相色谱法(HPLC)测定mEGF乙醇脂质体的包封率、精密度、回收率、稳定性,运用扫描电镜、原子力显微镜、透射电镜和激光粒度分析仪观察和分析mEGF乙醇脂质体囊泡的外观、粒径和均一度。结果 mEGF乙醇脂质体的包封率大约为38%,精密度小于5%,30 d内包封率波动在36%~38%之间。运用原子力显微镜和透射电镜观察到粒径分布于40~60 nm的乙醇脂质体囊泡。并且在激光动态光散射仪下测定显示囊泡的粒度分布较为均一,mEGF乙醇脂质体的折光度为4.6,囊泡粒径大约分布在100~500 nm之间。结论成功制备了mEGF乙醇脂质体,建立了测定包封率的色谱方法,该给药系统稳定性较好,乙醇脂质体囊泡粒径分布均匀。 Objective To prepare an ethosomal delivery system containing mouse epidermal growth factor(mEGF) and investigate its entrapment efficiency and physical properties.Methods The entrapment efficiency of mEGF ethosome(10 μg/g) was determined by high pressure liquid chromatography(HPLC).The mEGF ethosome vesicles were visualized by scanning electron microscopy(SEM),atomic force microscopy(AFM) and transmission electron microscopy(TEM).And the size distribution of ethosome vesicles was investigated using dynamic light scattering(DLS).Results The mEGF ethosome had an entrapment efficiency of 38% and the RSD was less than 5%.The entrapment efficiency of mEGF ethosomal carriers ranged from 36% to 38% during 30 d after having been prepared.mEGF ethosomal carriers had rather small vesicles in a size ranging from 40 nm to 60 nm visualized by AFM and TEM.And the size of the mEGF ethosomal delivery system had uniform distribution ranging from 100 nm to 500 nm.Also,the refractive index of the mEGF ethosomal delivery system was 4.6.ConclusionA mEGF ethosomal delivery system is successfully prepared.A HPLC method is developed to determine mEGF content in ethosomal delivery system.The delivery system shows a well stability and a narrow particle size distribution.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2011年第7期719-722,共4页 Journal of Third Military Medical University
基金 重庆市科技攻关计划项目(SWH2008003)~~
关键词 表皮生长因子 乙醇脂质体 高效液相色谱法 原子力显微镜 epidermal growth factor ethosome high pressure liquid chromatography atomic force microscope
  • 相关文献

参考文献12

  • 1Mak K K, Chart S Y. Epidermal growth factor as a biologic switch in hair growth cycle [ J ]. J Biol Chem, 2003,278 (28) : 26120 - 26126.
  • 2Hong J P, Jung H D, Kim Y W. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers [ J]. Ann Plast Surg, 2006, 56(4) : 394 -398.
  • 3Tarnawski A S, Jones M K. The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: involvement of EGF-R signal transduction pathways [ J ]. J Clin Gastroenterol, 1998, 27 ( Suppl 1 ) : S12 - S20.
  • 4Touitou E, Dayan N, Bergelson L, et al. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties [ J ]. J Control Release, 2000, 65 (3) : 403 - 418.
  • 5陈文浩,刘玉玲.含醇脂质体ethosomes的特性、透皮机制及应用[J].中国药学杂志,2003,38(7):490-493. 被引量:7
  • 6何颖娜,尚京川,张晓萍,母昭德,景淑华,封家富.高效液相色谱法测定人血浆中甲苯咪唑含量[J].第三军医大学学报,2005,27(20):2086-2087. 被引量:8
  • 7桂莉,田洪,郑健,段炜,叶枫.高效液相色谱荧光法同时测定小鼠脑组织中4种氨基酸类神经递质[J].第三军医大学学报,2009,31(8):675-678. 被引量:23
  • 8Dave V, Kumar D, Lewis S, et al. Ethosome for Enhanced Transdermal Drug Delivery of Aceclofenac [ J ]. International Journal of Drug Delivery, 2010, 2(1) : 81 -92.
  • 9Godin B, Touitou E. Mechanism of bacitraein permeation enhancement through the skin and cellular membranes from an ethosomal carrier[ J]. J Control Release, 2004, 94 (2/3) : 365 -379.
  • 10Verma D D, Fahr A. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A [ J ]. J Control Release, 2004,97 ( 1 ) : 55 - 66.

二级参考文献32

共引文献41

同被引文献19

  • 1王世岭,周亮,马建丽,杨珺,潘强,高振梅,高远征,郭华.重组人表皮细胞生长因子凝胶对家兔烫伤创面修复作用的研究[J].解放军药学学报,2005,21(5):348-351. 被引量:6
  • 2郑庆忠,刘利军.pH梯度法制备氧化苦参碱脂质体[J].中国医药工业杂志,2006,37(10):679-681. 被引量:14
  • 3Cohen S. Isolation of a mouse submaxillary gland protein acceleratingincisor eruption and eyelid opening in the new-born animal [J]. J BiolChem, 1962,237:1555-1562.
  • 4Cohen S,Carpenter G. Human epidermal growth factor: isolation andchemical and biological properties[J]. Proc Nat Acad Sci USA, 1975,72:1317-1321.
  • 5Hong J P, Jung H D, Kim Y W. Recombinant human epidermal growthfactor (EGF) to enhance healing for diabetic foot ulcers[J]. Ann PlastSurg, 2006, 56(4):394-398.
  • 6孙民富.一种含有表皮细胞生长因子(EGF)及透皮短肽融合蛋白的用于防治糖尿病足坏疽的脂质体的制备方法:中国,201010137432.9[P]. 2011-10-12.
  • 7蔡素芬,黄久遂.脂质体经皮给药研究进展[J].临床药学,2008,18(5): 56-58.
  • 8Liu S, Guo D, Guo, Y, et al. Preparation and pharmacokinetics of cef-tiofiir sodium liposomes in cows [J]. J Vet Pharmacol Therap, 2010,34:35-41.
  • 9Yang X,Zhao X,Phelps M A, et al. A novel liposomal formulation offlavopiridol [J]. International Journal of Pharmaceutics, 2009, 365(1-2):170-174.
  • 10王爱军,王凤山,王友联,等.低浓度蛋白含量测定方法的研究[J].中国生化药物杂,2003,4(2):78-80.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部